Clinical usefulness of electrophysiologic study (EPS)-guided risk stratification for life-threatening arrhythmia in patients with heart failure

International Heart Journal

Volumn 48, Issue 2, 2007, Pages 155-163

  Sasaki, Sae ^a   Niwano, Shinichi ^a   Fukaya, Hidehira ^a   Yuge, Masaru ^a   Imaki, Ryuta ^a   Inomata, Takayuki ^a   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Electrophysiologic study; Heart failure; Implantable cardioverter defibrillator; Ventricular fibrillatioin; Ventricular tachyarrhythmia

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; FATALITY; FEMALE; FOLLOW UP; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; SUDDEN DEATH;

ADULT; AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY, AMBULATORY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 34247113647     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.48.155     Document Type: Article

References (28)

1. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316:1429-35.
2. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
3. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991; 325:1468-75.
4. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 314:1547-52.
5. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfuncfton after myocardial infraction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992; 327:669-77.
6. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmicdrug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-83.
7. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350:2151-8.
8. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335:1933-40.
9. Winkle RA, Mead RH, Ruder MA, et al. Long-term outcome with the automatic implantable cardioverter defibrillator. J Am Coll Cardiol 1989; 13:1353-61.
10. Zipes DP, Roberts D. The Pacemaker-Cardioverter-Defibrillator Investigators. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead system Circulation 1995; 92:59-65.
11. Karaoguz R, Maydanozeu, Altun T, Guldal M, Akyurek O, Erol C. Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy, Int Heart J 2006; 47: 763-73.
12. Wilber DJ, Garan H, Finkelstein D, et al. Out-of-hospital cardiac arrest Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1998; 319: 19-24.
13. Niwano S, Yamaura M, Yoshizawa N, et al. Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study guided effective pharmacological therapy. Jpn Circ J 1999, 63: 674-80.
14. Josephson ME, Horowitz LN. Electrophysiologic approach to therapy of recurrent sustained ventricular tachycardia. Am J Cardiol 1979; 43: 63142. (Review)
15. Imaki R, Niwano S, Fukaya H, et al. Predictive impact of the inducibility of ventricular fibrillation in patients with Brugada-type ECG. Int Heart J 2006; 47: 229-36.
16. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-37.
17. Yuge M, Niwano S, Moriguchi M, et al. Clinical significance of the electrophysiologic study (EPS)-guided therapy for the secondary prevention of ventricular tachycardia. Circ J 2006; 70: 268-72.
18. Niwano S, Furushima. H, Taneda K, Abe A, Ohira K, Aizawa Y. The usefulness of Holter monitoring in selecting pharmacological therapy for patients with sustained monomorphic ventricular tachycardia: studies in patients in whom no effective pharmacologic therapy could be determined by electrophysiologic study. Jpn Circ J 1998; 62:347-52.
19. Mitchell LB, Sheldon RS, Gillis AM, et al. Definition of predicted effective antiarrhythmic drug therapy for ventricular tachyarrhythmias by the electrophysiologic study approach: randomized comparison of patient response criteria. J Am Coll Cardiol 1997; 30: 1346-53.
20. Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 2000; 342:1937-45.
21. Greene HL. The CASCADE Study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators. Am J Cardiol 1993; 72:70F-4.
22. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994; 344:493-8.
23. Savard. P, Rouleau JL, Ferguson J, et al. Risk stratification after myocardial infarction using signal-averaged electrocardiographic criteria adjusted for sex, age, and myocardial infraction location. Circulation 1997; 96: 202-13.
24. Schwartz P, Vanoli E, Stramba-Badiale M, De Ferrari GM, Billman GE, Foreman RD, Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988; 78:969-71.
25. Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ, Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994; 330:235-41.
26. Gillis AM, Sheldon RS, Wyse DG, Duff HJ, Cassidy MR, Mitchell LB. Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioventer defibrillators. J Cardiovasc Electrophysiol 2003; 14:492-8.
27. Raitt MH, Dolack GL, Kudenchuk PJ, Poole JE, Bardy GH. Ventricular arrhythmias detected after trasvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation. Implications for use of implantable defibrillator. Circulation 1995; 91: 1996-2001.
28. Brembilla-Perrot B, Suty-Selton C, Alla F, et al. Risk factors for cardiac mortality in cases of syncope with previous history of myocardial infraction. Arch Mal Coeur Vaiss 2003; 96: 1181-6. (French)